Dediabetes Logo
Preguntas
Respuestas publicadas conectadas con evidencia
Referencia clínica
Dossieres detallados de intervenciones y resultados
Investigacion reciente
Estudios mas recientes
Acerca de
Cómo funciona deDiabetes
Configuracion
Entrar / Unirse

Metformin Therapies for Diabetes - Evidence Strength

Ver informe de evidencia

Evidence on outcomes studied for Metformin

Evidence related to metformin therapies in diabetes studies.

Crea tu Evidence Workspace

Guarda evidencia sobre los temas que te importan.

40
Studies
100
Evidence Pairs
Moderate Evidence
Evidence Strength: 62/100
Evidence Intelligence™

Evidence Summary

A structured summary of where the evidence is strongest, mixed, or still emerging.

Executive Summary

Metformin evidence appears to center on Glucose iAUC (OGTT).

Among 40 indexed studies and 3 interventions, the strongest signals are summarized from the available evidence. HbA1c has been studied often, while Glucose iAUC (OGTT) appears to have stronger current evidence signals.

  • Evidence is consistently positive across multiple studies.
  • Some evidence is positive, but results are not consistent across all studies.
  • Early findings are encouraging, but stronger trials are needed.
Caution

This summary reflects the currently indexed evidence and should not be interpreted as treatment advice.

Key Finding

Evidence is consistently positive across multiple studies.

Interventions with strongest consistent evidence

Strongest consistent evidence

Why it matters

Consistent positive findings are easier to interpret than isolated or mixed results.

Interpretation

Glucose iAUC (OGTT) appears to have a consistent beneficial signal in the indexed evidence.

View supporting studies
Evidence basis: 5 evidence pairs - 20 studies

Why this appears here

Strong evidenceConsistent resultsPositive effect signalMultiple RCTsGenerally consistent
Glucose iAUC (OGTT)
6 studies
EvidenceScore™
83/100
ConsistencyScore™
36/100
Fasting Plasma Glucose (FPG)
7 studies
EvidenceScore™
84/100
ConsistencyScore™
69/100

Evidence Snapshot

40
Studies
3
Interventions
95
Outcomes
8
Strong evidence signals
8
Mixed evidence areas

Key Findings

Key patterns and insights identified across the research landscape

Strong positive signal

HbA1c

Across 12 studies, Metformin shows a strong positive signal for HbA1c.

12 studies
EvidenceScore™: 85.34615384615384/100
View supporting studies
Moderate positive signal

Fasting Plasma Glucose (FPG)

Across 7 studies, Metformin shows a moderate positive signal for Fasting Plasma Glucose (FPG).

7 studies
EvidenceScore™: 83.9010989010989/100
View supporting studies
Moderate positive signal

Body weight

Across 5 studies, Metformin shows a moderate positive signal for Body weight.

5 studies
EvidenceScore™: 83.07692307692308/100
View supporting studies
Moderate positive signal

Glucose iAUC (OGTT)

Across 6 studies, Metformin shows a consistent moderate positive signal for Glucose iAUC (OGTT).

6 studies
EvidenceScore™: 82.78205128205127/100
View supporting studies
Moderate positive signal

BMI

Across 4 studies, Metformin shows a moderate positive signal for BMI.

4 studies
EvidenceScore™: 79/100
View supporting studies

Supporting Evidence

Mixed or conflicting evidence

Some evidence is positive, but results are not consistent across all studies.

Areas where results are mixed

Why it matters

Mixed results suggest effects may depend on population, comparator, duration, or study design.

Interpretation

HbA1c is mixed in the currently indexed evidence.

Caution

Some supporting studies reported neutral, negative, or mixed findings.

Top entities

HbA1c
Body weight
HbA1c
14 studies
EvidenceScore™
85/100
ConsistencyScore™
70/100

Why this appears here

Mixed Or Conflicting ResultsPositive Signal PresentNeutral Results PresentNegative Results Present
Evidence basis: 9 evidence pairs - 23 studies
View supporting studies
Promising but understudied

Early findings are encouraging, but stronger trials are needed.

Promising areas needing more evidence

Why it matters

Promising signals can guide further review, but they should not be treated as settled evidence.

Interpretation

Insulin sensitivity may have a beneficial signal, but the evidence base is still developing.

Caution

Current support is limited by study volume, RCT depth, or evidence strength.

Top entities

Insulin sensitivity
Total daily insulin dose
Insulin sensitivity
4 studies
EvidenceScore™
79/100
ConsistencyScore™
36/100

Why this appears here

Positive effect signalLimited study volume
Evidence basis: 5 evidence pairs - 14 studies
View supporting studies

Explore the Evidence

The sections below provide the complete evidence questions, supporting relationships, and underlying studies behind the summary above.

Preguntas respondidas por la evidencia

What outcomes has Metformin been studied for?

HbA1c, Fasting Plasma Glucose (FPG), and Body weight are among the most studied areas in relation to Metformin.

Emerging Evidence · Consistency cannot yet be determined from the available evidence. · 40 studies · 40 RCTs

The evidence includes both beneficial and harmful or worsening results.

View top evidence signals ↓
  1. HbA1c · Strong · 14 studies
  2. Fasting Plasma Glucose (FPG) · Strong · 7 studies
  3. Body weight · Strong · 7 studies

Does Metformin lower HbA1c?

Metformin appears to lower HbA1c.

Strong Evidence · Results are generally consistent across studies. · 14 studies · 14 RCTs

View top evidence signals ↓
  1. HbA1c · Strong · 14 studies

Does Metformin affect body weight?

Metformin may affect body weight.

Strong Evidence · Results are mixed and should be interpreted cautiously. · 7 studies · 7 RCTs

The evidence includes both beneficial and harmful or worsening results.

View top evidence signals ↓
  1. Body weight · Strong · 7 studies

Which outcomes have the strongest evidence for Metformin?

HbA1c, Fasting Plasma Glucose (FPG), and Body weight have the strongest available evidence signals for Metformin.

Strong Evidence · Results are generally consistent across studies. · 24 studies · 24 RCTs

The evidence includes both beneficial and harmful or worsening results.

View top evidence signals ↓
  1. HbA1c · Strong · 14 studies
  2. Fasting Plasma Glucose (FPG) · Strong · 7 studies
  3. Body weight · Strong · 7 studies

Where does Metformin need more research?

Proportion achieving HbA1c <7.0%, Waist circumference, and LDL cholesterol need more research in relation to Metformin.

Moderate Evidence · Results are mixed and should be interpreted cautiously. · 9 studies · 9 RCTs

The evidence includes both beneficial and harmful or worsening results.

View top evidence signals ↓
  1. LDL cholesterol · Moderate · 2 studies
  2. Waist circumference · Moderate · 2 studies
  3. Proportion achieving HbA1c <7.0% · Moderate · 2 studies
Browse all questions about Metformin

Overall Evidence Signals

Among 40 indexed studies and 3 interventions, the strongest signals are summarized from the available evidence. HbA1c has been studied often, while Glucose iAUC (OGTT) appears to have stronger current evidence signals.

  • Evidence is consistently positive across multiple studies.
  • Some evidence is positive, but results are not consistent across all studies.
  • Early findings are encouraging, but stronger trials are needed.

Evidence Relationships

Explore the intervention-outcome relationships with the strongest supporting evidence for Metformin.

9 strong relationships, ranked by available evidence

View every intervention-outcome relationship included in this topic.

Select any relationship to review its supporting studies.

Studies evaluating Metformin

Studies connected to this intervention in the evidence record.

Click outcomes and interventions to filter Evidence Explorer when links are available.

Evidence Tracker

Track Metformin Therapies for Diabetes - Evidence Strength evidence

Save this evidence topic and revisit it as new studies are added.